Prager R, Schernthaner G
Diabetologia. 1983 Sep;25(3):235-7. doi: 10.1007/BF00279935.
In the present study insulin binding properties of human semi-synthetic and porcine insulin were compared in Type 1 (insulin-dependent) diabetic patients treated from the onset of their disease either with human semi-synthetic insulin (n = 12) or porcine insulin (n = 12) and control subjects (n = 12). In all three groups, insulin binding to circulating monocytes revealed no difference between human semi-synthetic and porcine insulin (specific insulin binding at tracer concentration: 5.7 +/- 0.5% versus 5.4 +/- 0.5% in control subjects, 5.5 +/- 0.4% versus 5.4 +/- 0.4% in Type 1 diabetic patients on porcine insulin, 5.3 +/- 0.4% versus 5.6 +/- 0.4% in Type 1 diabetic patients on human insulin). Treatment with human or porcine insulin did not have any significant influence on receptor binding properties of the two diabetic groups investigated. Absolute receptor number and affinity of both diabetic groups were within the range of healthy control subjects irrespective of treatment with human or porcine insulin.
在本研究中,对1型(胰岛素依赖型)糖尿病患者的人半合成胰岛素和猪胰岛素的胰岛素结合特性进行了比较。这些患者自疾病发作起就分别接受人半合成胰岛素治疗(n = 12)或猪胰岛素治疗(n = 12),并与对照组(n = 12)进行对比研究。在所有三组中,胰岛素与循环单核细胞的结合显示,人半合成胰岛素和猪胰岛素之间没有差异(示踪剂浓度下的特异性胰岛素结合:对照组为5.7±0.5% 对5.4±0.5%;接受猪胰岛素治疗的1型糖尿病患者为5.5±0.4% 对5.4±0.4%;接受人胰岛素治疗的1型糖尿病患者为5.3±0.4% 对5.6±0.4%)。用人胰岛素或猪胰岛素治疗对所研究的两个糖尿病组的受体结合特性没有任何显著影响。无论接受人胰岛素还是猪胰岛素治疗,两个糖尿病组的绝对受体数量和亲和力均在健康对照组的范围内。